MAPT and Alzheimer disease: Although NFTs have been assumed to be the main pathological hallmark in tauopathies, recent studies have demonstrated that the accumulation of the smaller, soluble and dynamic tau oligomers, as well as neuronal loss, precede the formation of NFTs and the clinical manifestation of AD symptomatology10,11.